News-EN - Page 33

In a year marked by shifts in the pharmaceutical landscape, Humana Inc. (NYSE:HUM) stands out as a strategic player amid a bustling industry scenario. While 2024 saw a steady stream of smaller, more tactical mergers, the overarching pharmaceutical sector is gearing up

In recent developments, Acelyrin Inc. faces a mixed bag of news as it navigates clinical and financial territories. The company’s clinical trial for its drug, izokibep, aimed at treating uveitis, did not meet its primary goal. When compared with a placebo, both

SpaceX Surges Ahead in Satellite Communications SpaceX has significantly enhanced its position in the direct-to-cell (DTC) communication market, challenging smaller competitors like AST SpaceMobile. Earlier predictions underestimated SpaceX’s swift progress in deploying Starlink satellites capable of facilitating direct calls between regular cell

The stock market’s impressive performance in 2024 faces a significant challenge: persistently high bond yields. After experiencing a downturn in April, Treasury yields began a sharp rise in mid-September, driven by evolving dynamics in the fixed-income market. The 10-year Treasury yield, a

Boeing is facing renewed scrutiny as one of its aircraft, operated by Jeju Air, crash-landed dramatically at Muan International Airport, South Korea. The Boeing 737-800, an aircraft from Boeing’s older jet series, made a catastrophic belly landing after its landing gear failed

Wall Street Wobbles as Year-End Nears Investor optimism took a hit on Monday as all major indices experienced declines. The S&P 500 (^GSPC) saw a drop of about 1.6%, paralleling the Nasdaq Composite’s (^IXIC) 1.7% slump. Even the Dow Jones Industrial Average

US markets faced a turbulent start to the week, reflecting increased volatility as the year-end approaches. The Nasdaq 100 witnessed a significant dip, dropping nearly 5% as soaring bond yields put additional pressure on stock values. Meanwhile, the S&P 500 isn’t faring